Phase I trial of HS 25, a statin compound to treat primary hypercholesterolaemia and nephrotic hyperlipidaemia

Trial Profile

Phase I trial of HS 25, a statin compound to treat primary hypercholesterolaemia and nephrotic hyperlipidaemia

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2014

At a glance

  • Drugs Hyzetimibe (Primary)
  • Indications Hypercholesterolaemia; Hyperlipidaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Mar 2014 Status changed from planning to completed.
    • 24 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top